94 related articles for article (PubMed ID: 8910928)
1. Mechanisms of proteinuria: vascular permeability factor in congenital nephrotic syndrome of the Finnish type.
Haltia A; Solin ML; Jalanko H; Holmberg C; Miettinen A; Holthöfer H
Pediatr Res; 1996 Nov; 40(5):652-7. PubMed ID: 8910928
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF
Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
[TBL] [Abstract][Full Text] [Related]
4. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
5. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
Brown LF; Detmar M; Tognazzi K; Abu-Jawdeh G; Iruela-Arispe ML
Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161
[TBL] [Abstract][Full Text] [Related]
6. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
[TBL] [Abstract][Full Text] [Related]
8. Glomerular endothelium in kidneys with congenital nephrotic syndrome of the Finnish type (NPHS1).
Kaukinen A; Kuusniemi AM; Lautenschlager I; Jalanko H
Nephrol Dial Transplant; 2008 Apr; 23(4):1224-32. PubMed ID: 18048423
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
Brown LF; Olbricht SM; Berse B; Jackman RW; Matsueda G; Tognazzi KA; Manseau EJ; Dvorak HF; Van de Water L
J Immunol; 1995 Mar; 154(6):2801-7. PubMed ID: 7876550
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.
Shulman K; Rosen S; Tognazzi K; Manseau EJ; Brown LF
J Am Soc Nephrol; 1996 May; 7(5):661-6. PubMed ID: 8738799
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.
Couffinhal T; Kearney M; Witzenbichler B; Chen D; Murohara T; Losordo DW; Symes J; Isner JM
Am J Pathol; 1997 May; 150(5):1673-85. PubMed ID: 9137092
[TBL] [Abstract][Full Text] [Related]
12. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
13. Vascular permeability factor mRNA and protein expression in human kidney.
Brown LF; Berse B; Tognazzi K; Manseau EJ; Van de Water L; Senger DR; Dvorak HF; Rosen S
Kidney Int; 1992 Dec; 42(6):1457-61. PubMed ID: 1474780
[TBL] [Abstract][Full Text] [Related]
14. Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).
Kondo S; Yoshizawa N; Kusumi Y; Takeuchi A; Torikata C
Clin Nephrol; 1999 Nov; 52(5):278-84. PubMed ID: 10584990
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
[TBL] [Abstract][Full Text] [Related]
16. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes.
Bogic LV; Brace RA; Cheung CY
Placenta; 2001 Apr; 22(4):265-75. PubMed ID: 11286562
[TBL] [Abstract][Full Text] [Related]
17. Noncollagenous matrix components of glomeruli in congenital nephrotic syndrome of the Finnish type: evidence of abnormal splitting of nidogen?
Ljungberg P; Haltia A; Kuusela P; Jalanko H; Holmberg C; Holthöfer H
Exp Nephrol; 1996; 4(5):286-94. PubMed ID: 8931984
[TBL] [Abstract][Full Text] [Related]
18. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
[TBL] [Abstract][Full Text] [Related]
19. Renal pathology in congenital nephrotic syndrome of Finnish type: a quantitative light microscopic study on 50 patients.
Huttunen NP; Rapola J; Vilska J; Hallman N
Int J Pediatr Nephrol; 1980 Mar; 1(1):10-6. PubMed ID: 7343522
[TBL] [Abstract][Full Text] [Related]
20. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
